Emcure Pharmaceuticals Limited (NSE:EMCURE)
1,433.90
-50.70 (-3.42%)
Jan 28, 2026, 3:10 PM IST
11.65% (1Y)
| Market Cap | 281.44B |
| Revenue (ttm) | 84.49B +16.4% |
| Net Income | 7.93B +39.8% |
| EPS | 41.87 +35.0% |
| Shares Out | 189.57M |
| PE Ratio | 35.46 |
| Forward PE | 27.30 |
| Dividend | 3.00 (0.20%) |
| Ex-Dividend Date | Aug 14, 2025 |
| Volume | 125,748 |
| Average Volume | 242,132 |
| Open | 1,495.00 |
| Previous Close | 1,484.60 |
| Day's Range | 1,427.00 - 1,511.80 |
| 52-Week Range | 889.00 - 1,585.60 |
| Beta | n/a |
| RSI | 49.17 |
| Earnings Date | Feb 4, 2026 |